SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-22-004671
Filing Date
2022-03-02
Accepted
2022-03-02 16:03:56
Documents
94
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K avtx-20211231.htm   iXBRL 10-K 2434276
2 EX-4.15 ex-415descriptionofregiste.htm EX-4.15 42694
3 EX-10.5 ex-105_nonemployeedirector.htm EX-10.5 20404
4 EX-21.1 ex-211listofsubsidiariesof.htm EX-21.1 3300
5 EX-23.1 ex-2312021.htm EX-23.1 15345
6 EX-31.1 ex-3112021.htm EX-31.1 10633
7 EX-31.2 ex-3122021.htm EX-31.2 10419
8 EX-32.1 ex-3212021.htm EX-32.1 10837
14 GRAPHIC avtx-20211231_g1.jpg GRAPHIC 457653
  Complete submission text file 0001628280-22-004671.txt   12072271

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT avtx-20211231.xsd EX-101.SCH 78906
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT avtx-20211231_cal.xml EX-101.CAL 100991
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT avtx-20211231_def.xml EX-101.DEF 473104
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT avtx-20211231_lab.xml EX-101.LAB 961659
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT avtx-20211231_pre.xml EX-101.PRE 668281
88 EXTRACTED XBRL INSTANCE DOCUMENT avtx-20211231_htm.xml XML 1578239
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Filer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37590 | Film No.: 22703350
SIC: 2834 Pharmaceutical Preparations